Altre lingue Orient EuroPharma Co., Ltd.

Azioni

4120

TW0004120001

Prezzo di chiusura Taipei Exchange Altri mercati azionari 00:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
42,2 ^TWD	+2,30%		+3,43%	+8,48%

01/03	Orient EuroPharma Co., Ltd. Riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Orient EuroPharma Co., Ltd. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Regeneus Ltd announced that it expects to receive AUD 3.481164 million in funding from Zheng Yang Biomedical Technology Co., Ltd., Orient EuroPharma Co., Ltd. and other investors	05/04
Orient EuroPharma Co., Ltd. announced that it expects to receive TWD 300 million in funding	29/03
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/03
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23
Orient EuroPharma Co., Ltd. Appoints Jack Wang as Accounting Officer	10/08/23
Orient EuroPharma Co., Ltd. Appoints Jack Wang as Financial Officer	01/08/23
Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Orient EuroPharma, OncoVent Sign License Deal	30/03/23
OncoVent Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab	28/03/23
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	07/03/23
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	07/03/23
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/11/22
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	09/08/22
Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	14/05/22
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/02/22
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	11/11/21
Orient Europharma Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	12/08/21
Orient Europharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	12/05/21
Orient Europharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	25/02/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Orient EuroPharma Co., Ltd.

Azioni

4120

TW0004120001

Altre lingue

Filtri